BIOMAT Database Logo BIOMAT Database Logo

Hook effect in immunometric assays for prostate-specific antigen. 1995

A Charrié, and G Charriére, and A Guerrier

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005188 False Negative Reactions Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Negative Reaction,Reaction, False Negative,Reactions, False Negative
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein

Related Publications

A Charrié, and G Charriére, and A Guerrier
More on "hook effects" in immunometric assays for prostate-specific antigen.
October 1989, Clinical chemistry,
A Charrié, and G Charriére, and A Guerrier
More on "hook effects" in immunometric assays for prostate-specific antigen.
June 1989, Clinical chemistry,
A Charrié, and G Charriére, and A Guerrier
Shifting the "hook effect" in one-step immunometric assays.
January 1990, Clinical chemistry,
A Charrié, and G Charriére, and A Guerrier
Cost-effective method for detection of "hook effect" in tumor marker immunometric assays.
April 1993, Clinical chemistry,
A Charrié, and G Charriére, and A Guerrier
The establishment and evaluation of luminescent-labelled immunometric assays for prostate-specific antigen-alpha 1-antichymotrypsin complexes in serum.
December 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies,
A Charrié, and G Charriére, and A Guerrier
"High-dose hook effect" in IRMA-Count PSA assay of prostate-specific antigen.
May 1991, Clinical chemistry,
A Charrié, and G Charriére, and A Guerrier
Comparison of prostate specific antigen assays.
January 1991, European journal of cancer (Oxford, England : 1990),
A Charrié, and G Charriére, and A Guerrier
Use of prostate specific antigen assays.
August 1995, American journal of clinical pathology,
A Charrié, and G Charriére, and A Guerrier
The effect of different assays on prostate-specific antigen testing.
June 2023, BJU international,
A Charrié, and G Charriére, and A Guerrier
Clinical usefulness of assays for complexed prostate-specific antigen.
February 2002, The Urologic clinics of North America,
Copied contents to your clipboard!